[Webinar on 11/7] What is the 2025 Amendment to the Pharmaceutical and Medical Device Act? One-stop explanation of quality assurance and stable supply countermeasures.

The amendment to the Pharmaceutical and Medical Device Act, which will be promulgated in May 2025 and is scheduled to be implemented in phases starting in November, will introduce new institutional requirements regarding the strengthening of the quality management system for pharmaceuticals and the responsibility for stable supply.
In this webinar, Agatha, which specializes in document and quality management, and Resilire Co., Ltd., which supports supply chain management and the realization of stable supply, will co-host to organize the challenges anticipated in the field against the backdrop of the amendment to the Pharmaceutical and Medical Device Act and introduce specific methods to support quality management and stable supply.
[Program]
Greeting: 14:00–14:05
"Explanation of the purpose and background of this webinar"
Part 1: 14:05–14:25
"Utilization of Agatha solutions in light of the direction of the new system"
Quality Group, Sales & Marketing Department, Agatha Inc.
Part 2: 14:25–14:50
"Desired stable supply system and supply chain management by Resilire"
Hiroshi Urayama, Director of Business Development, Resilire Co., Ltd.
Part 3: 14:50–15:00
"Q&A Session"
*Questions will be collected during the webinar.

Date and time | Friday, Nov 07, 2025 02:00 PM ~ 03:00 PM |
---|---|
Entry fee | Free |
Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration